Articles by Cynthia Challener, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Cynthia Challener, PhD

Monoclonal Antibodies Key to Unlocking the Biosimilars Market

The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth.
Apr 1, 2014

The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth.

Predicting Lyophilization Performance

Researchers are using current understanding of the lyophilization process to predict performance on many levels during both process development and manufacturing.
Mar 1, 2014

Researchers are using current understanding of the lyophilization process to predict performance on many levels during both process development and manufacturing.

Advances in Linker Technology

The targeted delivery of cytotoxic drugs using antibody drug conjugates would not be possible without effective linkers to connect and then release the key chemical and biological materials.
Mar 1, 2014

The targeted delivery of cytotoxic drugs using antibody drug conjugates would not be possible without effective linkers to connect and then release the key chemical and biological materials.

Advances in UPLC Techniques and Column Chemistry Aid the Confirmation of Biosimilarity

Automated sample handling, advanced glycan analysis and specially designed columns are helping biosimilar manufacturers speed up confirmation of the biosimilarity of their products.
Feb 1, 2014

Automated sample handling, advanced glycan analysis and specially designed columns are helping biosimilar manufacturers speed up confirmation of the biosimilarity of their products.

Tackling the Challenge of Higher-Order Structure Determination

Advances in instrumentation, software, and methodologies are providing more information than ever on the higher-order structure of proteins.
Feb 1, 2014

Advances in instrumentation, software, and methodologies provide more information than ever on the higher-order structure of proteins.

How Will CMOs Provide Sufficient Capacity for Growing Biologics Demand

Jan 31, 2014

With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.

Progress in the Prediction of Protein Aggregation

Techniques to enable the design and formulation of stable, protein-based therapeutics.
Jan 1, 2014

Techniques to enable the design and formulation of stable, protein-based therapeutics.

Single-Use Continuous Chromatography Overcoming Limitations of Traditional Protein Purification

Aug 20, 2013

Continuous countercurrent tangential chromatography (CCTC) is a column-free process that provides a scalable, disposable, and cost-saving alternative to column chromatography.

EMD Millipore, PharmaCell Collaborate on Large-Scale Bioreactor Production of Stem Cells

Aug 16, 2013

EMD Millipore and PharmaCell have entered into a collaboration to develop optimized large-scale expansion and harvest of HepaRG cells using bioreactor technology.

ADVERTISEMENT

ADVERTISEMENT

Click here